Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,581 | -11,105 | -8,184 | -4,510 | -331,942 |
| Depreciation Amortization | 26,268 | 18,906 | 12,622 | 5,803 | 28,684 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 76,201 |
| Accounts receivable | -6,457 | 2,719 | 7,750 | 5,054 | 48,669 |
| Other Working Capital | 5,204 | -2,103 | 4,288 | 3,580 | 140 |
| Other Operating Activity | 22,974 | 6,443 | -1,581 | -2,419 | 227,852 |
| Operating Cash Flow | $26,408 | $14,860 | $14,895 | $7,508 | $49,604 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -48,911 | -50,029 | -43,320 | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -628 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 1,531 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 2,194 |
| Investing Cash Flow | $-48,911 | $-50,029 | $-43,320 | $N/A | $3,097 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -10,500 |
| Other Financing Activity | -350 | -291 | -281 | -206 | -33,701 |
| Financing Cash Flow | $-350 | $-291 | $-281 | $-206 | $-44,201 |
| Beginning Cash Position | 73,441 | 73,441 | 73,441 | 73,441 | 64,941 |
| End Cash Position | 50,588 | 37,981 | 44,735 | 80,743 | 73,441 |
| Net Cash Flow | $-22,853 | $-35,460 | $-28,706 | $7,302 | $8,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 26,408 | 14,860 | 14,895 | 7,508 | 49,604 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -628 |
| Free Cash Flow | 26,408 | 14,860 | 14,895 | 7,508 | 48,976 |